Mumps is?a viral infection that primarily affects saliva-producing (salivary) glands?that are located near your ears. Mumps can cause swelling in one or both of these glands. Mumps was common in the United States until mumps vaccination became routine.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Mumps industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Monovalent Vaccine
Polyvalent Vaccine
Market Segment by Product Application
Immune Center
Vaccine Development Agencies and Organizations
Hospital
Laboratory
Biotechnology and Biopharmaceutical Companies
Research Methodology
Finally, the report provides detailed profile and data information analysis of leading company.
Medlmmune
Johnson & Johnson
Merck
Sanofi
Serum
Bavarian Nordic
Astellas Pharma
Emergent BioSolutions
GlaxoSmithKline
Pfizer
CSL
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Mumps consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Mumps market by identifying its various subsegments.
3.Focuses on the key global Mumps manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Mumps with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Mumps submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Mumps Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Mumps Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Mumps Segment by Type
2.1.1 Monovalent Vaccine
2.1.2 Polyvalent Vaccine
2.2 Market Analysis by Application
2.2.1 Immune Center
2.2.2 Vaccine Development Agencies and Organizations
2.2.3 Hospital
2.2.4 Laboratory
2.2.5 Biotechnology and Biopharmaceutical Companies
2.2.6 Research Methodology
2.3 Global Mumps Market Comparison by Regions (2017-2027)
2.3.1 Global Mumps Market Size (2017-2027)
2.3.2 North America Mumps Status and Prospect (2017-2027)
2.3.3 Europe Mumps Status and Prospect (2017-2027)
2.3.4 China Mumps Status and Prospect (2017-2027)
2.3.5 Japan Mumps Status and Prospect (2017-2027)
2.3.6 Southeast Asia Mumps Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Mumps Industry Impact
2.5.1 Mumps Business Impact Assessment - Covid-19
2.5.2 Market Trends and Mumps Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Mumps Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Mumps Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Mumps Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Mumps Manufacturer Market Share
3.5 Top 10 Mumps Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Mumps Market
3.7 Key Manufacturers Mumps Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Mumps Industry Key Manufacturers
4.1 Medlmmune
4.1.1 Compan Detail
4.1.2 Medlmmune Mumps Product Introduction, Application and Specification
4.1.3 Medlmmune 161 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Medlmmune News
4.2 Johnson & Johnson
4.2.1 Compan Detail
4.2.2 Johnson & Johnson Mumps Product Introduction, Application and Specification
4.2.3 Johnson & Johnson Mumps Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Medlmmune News
4.3 Merck
4.3.1 Compan Detail
4.3.2 Merck Mumps Product Introduction, Application and Specification
4.3.3 Merck Mumps Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Merck News
4.4 Sanofi
4.4.1 Compan Detail
4.4.2 Sanofi Mumps Product Introduction, Application and Specification
4.4.3 Sanofi Mumps Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Sanofi News
4.5 Serum
4.5.1 Compan Detail
4.5.2 Sanofi Mumps Product Introduction, Application and Specification
4.5.3 Serum Mumps Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Serum News
4.6 Bavarian Nordic
4.6.1 Compan Detail
4.6.2 Bavarian Nordic Mumps Product Introduction, Application and Specification
4.6.3 Bavarian Nordic Mumps Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Bavarian Nordic News
4.7 Astellas Pharma
4.7.1 Compan Detail
4.7.2 Astellas Pharma Mumps Product Introduction, Application and Specification
4.7.3 Astellas Pharma Mumps Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Emergent BioSolutions
4.8.1 Compan Detail
4.8.2 Emergent BioSolutions Mumps Product Introduction, Application and Specification
4.8.3 Emergent BioSolutions Mumps Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Emergent BioSolutions News
4.9 GlaxoSmithKline
4.9.1 Compan Detail
4.9.2 GlaxoSmithKline Mumps Product Introduction, Application and Specification
4.9.3 GlaxoSmithKline Mumps Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 GlaxoSmithKline News
4.10 Pfizer
4.10.1 Compan Detail
4.10.2 Pfizer Mumps Product Introduction, Application and Specification
4.10.3 Pfizer Mumps Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Pfizer News
4.11 CSL
4.11.1 Compan Detail
4.11.2 CSL Mumps Product Introduction, Application and Specification
4.11.3 CSL Mumps Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 CSL News
5 Global Mumps Market Segment by Big Type
5.1 Global Mumps Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Mumps Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Mumps Revenue and Market Share by Big Type (2017-2022)
5.2 Monovalent Vaccine Sales Growth Rate and Price
5.2.1 Global Monovalent Vaccine Sales Growth Rate (2017-2022)
5.2.2 Global Monovalent Vaccine Price (2017-2022)
5.3 Polyvalent Vaccine Sales Growth Rate and Price
5.3.1 Global Polyvalent Vaccine Sales Growth Rate (2017-2022)
5.3.2 Global Polyvalent Vaccine Price (2017-2022)
6 Global Mumps Market Segment by Big Application
6.1 Global Mumps Sales Market Share by Big Application (2017-2022)
6.2 Immune Center Sales Growth Rate (2017-2022)
6.3 Vaccine Development Agencies and Organizations Sales Growth Rate (2017-2022)
6.4 Hospital Sales Growth Rate (2017-2022)
6.5 Laboratory Sales Growth Rate (2017-2022)
6.6 Biotechnology and Biopharmaceutical Companies Sales Growth Rate (2017-2022)
6.7 Research Methodology Sales Growth Rate (2017-2022)
7 Global Mumps Forecast
7.1 Global Mumps Revenue, Sales and Growth Rate (2022-2027)
7.2 Mumps Market Forecast by Regions (2022-2027)
7.2.1 North America Mumps Market Forecast (2022-2027)
7.2.2 Europe Mumps Market Forecast (2022-2027)
7.2.3 China Mumps Market Forecast (2022-2027)
7.2.4 Japan Mumps Market Forecast (2022-2027)
7.2.5 Southeast Asia Mumps Market Forecast (2022-2027)
7.2.6 Other Regions Mumps Market Forecast (2022-2027)
7.3 Mumps Market Forecast by Type (2022-2027)
7.3.1 Global Mumps Sales Forecast by Type (2022-2027)
7.3.2 Global Mumps Market Share Forecast by Type (2022-2027)
7.4 Mumps Market Forecast by Application (2022-2027)
7.4.1 Global Mumps Sales Forecast by Application (2022-2027)
7.4.2 Global Mumps Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Mumps Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Mumps Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Mumps
Figure Market Concentration Ratio and Market Maturity Analysis of Mumps
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Mumps Market Size by Big Type
Figure Global Market Share of Mumps by Big Type in 2021
Figure Monovalent Vaccine Picture (2017-2022)
Global Mumps Market Size by Big Application
Table Global Mumps Market Size by Application
Figure Global Mumps Market Share by Big Application in 2021
Figure Immune Center Picture
Figure Vaccine Development Agencies and Organizations Picture
Figure Hospital Picture
Figure Laboratory Picture
Figure Biotechnology and Biopharmaceutical Companies Picture
Figure Research Methodology Picture
Table Global Mumps Comparison by Regions (M USD) ?2017-2027?
Figure Global Mumps Market Size (Million US$) (2017-2027)
Figure North America Mumps Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Mumps Revenue (Million US$) Growth Rate (2017-2027)
Figure China Mumps Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Mumps Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Mumps Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Mumps Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Mumps Sales by Manufacturer (2017-2022)
Figure Global Mumps Sales Market Share by Manufacturer in 2021
Table Global Mumps Revenue by Manufacturer (2017-2022)
Figure Global Mumps Revenue Market Share by Manufacturer in 2021
Table Global Mumps Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Mumps Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Mumps Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Mumps Market
Table Key Manufacturers Mumps Product Type
Table Mergers & Acquisitions Planning
Table Medlmmune Company Profile
Table Mumps Product Introduction, Application and Specification of Medlmmune
Table Mumps Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Johnson & Johnson Company Profile
Table Mumps Product Introduction, Application and Specification of Johnson & Johnson
Table Mumps Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson Recent Development
Table Merck Company Profile
Table Mumps Product Introduction, Application and Specification of Merck
Table Mumps Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck Main Business
Table Merck Recent Development
Table Sanofi Company Profile
Table Mumps Product Introduction, Application and Specification of Sanofi
Table Mumps Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi Main Business
Table Sanofi Recent Development
Table Sanofi Main Business
Table Sanofi Recent Development
Table Serum Company Profile
Table Mumps Product Introduction, Application and Specification of Serum
Table Mumps Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Serum Main Business
Table Serum Recent Development
Table Bavarian Nordic Company Profile
Table Mumps Product Introduction, Application and Specification of Bavarian Nordic
Table Mumps Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bavarian Nordic Main Business
Table Bavarian Nordic Recent Development
Table Astellas Pharma Company Profile
Table Mumps Product Introduction, Application and Specification of Astellas Pharma
Table Mumps Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Astellas Pharma Main Business
Table Astellas Pharma Recent Development
Table Emergent BioSolutions Company Profile
Table Mumps Product Introduction, Application and Specification of Emergent BioSolutions
Table Mumps Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Emergent BioSolutions Main Business
Table Emergent BioSolutions Recent Development
Table GlaxoSmithKline Company Profile
Table Mumps Product Introduction, Application and Specification of GlaxoSmithKline
Table Mumps Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GlaxoSmithKline Main Business
Table GlaxoSmithKline Recent Development
Table Pfizer Company Profile
Table Mumps Product Introduction, Application and Specification of Pfizer
Table Mumps Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Table CSL Company Profile
Table Mumps Product Introduction, Application and Specification of CSL
Table Mumps Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table CSL Main Business
Table CSL Recent Development
Figure Global Mumps Sales and Growth Rate (2017-2022)
Figure Global Mumps Revenue and Growth Rate (2017-2022)
Table Global Mumps Sales by Regions (2017-2022)
Figure Global Mumps Sales Market Share by Regions in 2021
Table Global Mumps Revenue by Regions (2017-2022)
Figure Global Mumps Revenue Market Share by Regions in 2021
Figure North America Mumps Sales and Growth Rate (2017-2022)
Figure Europe Mumps Sales and Growth Rate (2017-2022)
Figure China Mumps Sales and Growth Rate (2017-2022)
Figure Japan Mumps Sales and Growth Rate (2017-2022)
Figure Southeast Asia Mumps Sales and Growth Rate (2017-2022)
Figure Other Regions Mumps Sales and Growth Rate (2017-2022)
Table Global Mumps Sales by Big Type (2017-2022)
Table Global Mumps Sales Market Share by Big Type (2017-2022)
Figure Global Mumps Sales Market Share by Big Type in 2019
Table Global Mumps Revenue by Big Type (2017-2022)
Table Global Mumps Revenue Market Share by Big Type (2017-2022)
Table Global Mumps Revenue Market Share by Big Type in 2019
Figure Global Monovalent Vaccine Sales Growth Rate (2017-2022)
Figure Global Monovalent Vaccine Price (2017-2022)
Figure Global Polyvalent Vaccine Sales Growth Rate (2017-2022)
Table Global Mumps Sales by Big Application (2017-2022)
Table Global Mumps Sales Market Share by Big Application (2017-2022)
Figure Global Mumps Sales Market Share by Big Application in 2019
Figure Global Immune Center Sales Growth Rate (2017-2022)
Figure Global Vaccine Development Agencies and Organizations Sales Growth Rate (2017-2022)
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Laboratory Sales Growth Rate (2017-2022)
Figure Global Biotechnology and Biopharmaceutical Companies Sales Growth Rate (2017-2022)
Figure Global Research Methodology Sales Growth Rate (2017-2022)
Figure Global Mumps Sales and Growth Rate (2022-2027)
Figure Global Mumps Revenue and Growth Rate (2022-2027)
Table Global Mumps Sales Forecast by Regions (2022-2027)
Table Global Mumps Market Share Forecast by Regions (2022-2027)
Figure North America Sales Mumps Market Forecast (2022-2027)
Figure Europe Sales Mumps Market Forecast (2022-2027)
Figure China Sales Mumps Market Forecast (2022-2027)
Figure Japan Sales Mumps Market Forecast (2022-2027)
Figure Southeast Asia Sales Mumps Market Forecast (2022-2027)
Figure Other Regions Sales Mumps Market Forecast (2022-2027)
Table Global Mumps Sales Forecast by Type (2022-2027)
Table Global Mumps Market Share Forecast by Type (2022-2027)
Table Global Mumps Sales Forecast by Application (2022-2027)
Table Global Mumps Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Mumps
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Mumps Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Mumps Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Mumps Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Mumps Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Mumps Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Mumps Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Mumps Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Mumps Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Medlmmune
Johnson & Johnson
Merck
Sanofi
Serum
Bavarian Nordic
Astellas Pharma
Emergent BioSolutions
GlaxoSmithKline